VG insider files Rule 144 notice to sell 94,145 shares on NYSE

Rhea-AI Filing Summary

Venture Global, Inc. (VG) filed a Form 144 notice reporting a proposed sale of 94,145 common shares with an aggregate market value of $1,224,468.70. The shares represent part of the company's 459,342,313 outstanding shares and the sale is planned on the NYSE on 08/21/2025.

The filing states the shares were acquired on 08/21/2025 by exercise of options under a registered plan from the issuer and paid in cash. No other sales by the reporting person were reported in the past three months. The notice includes the standard signer representation that no undisclosed material adverse information is known.

Positive

• Clear disclosure of the number of shares (94,145) and aggregate market value ($1,224,468.70)
• Acquisition and payment details are provided: exercise of options under a registered plan and cash payment

Negative

• Insider sale planned, which increases available shares in the market
• No additional context on the officer's rationale beyond the required representation

Insights

Securities Analyst

TL;DR: Routine Form 144 disclosing an insider sale following option exercise; likely immaterial given size versus outstanding shares.

The filing documents a planned sale of 94,145 shares following same-day exercise of options under a registered plan. The aggregate value of roughly $1.22 million is explicit in the filing. Compared with 459 million shares outstanding, this sale is a small fraction and appears procedural rather than a strategic shift. Absence of any sales in the prior three months reduces signs of accelerated liquidation. Material impact on valuation is likely minimal.

Corporate Governance Expert

TL;DR: Disclosure follows required compliance steps; filing shows adherence to Rule 144 mechanics and issuer-registered option exercise.

The notice clarifies both acquisition method (exercise under a registered plan) and intent to sell, which supports transparent reporting and compliance with Rule 144. The representation that no undisclosed material adverse information exists is standard. For governance review, the filing signals routine insider monetization rather than governance disruption.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	94145	1224468.70	459342313	08/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/21/2025	Exercise of options under a registered plan	Issuer			94145	08/21/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Venture Global's Form 144 (VG) report?

The filing reports a proposed sale of 94,145 common shares valued at $1,224,468.70 to be sold on 08/21/2025 on the NYSE.

How were the shares acquired that the filer intends to sell?

The shares were acquired on 08/21/2025 through exercise of options under a registered plan and payment was made in cash.

Has the filer sold other Venture Global shares in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

What portion of Venture Global's outstanding shares does the sale represent?

The company has 459,342,313 shares outstanding; the sale of 94,145 shares represents a very small fraction of total outstanding shares.

Does the Form 144 indicate any undisclosed material information about Venture Global?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.